• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation of the Georgian Version of the Multiple Sclerosis Quality of Life-54 (MSQOL-54) Questionnaire for Assessing the Quality of Life in Patients With Multiple Sclerosis.用于评估多发性硬化症患者生活质量的格鲁吉亚语版多发性硬化症生活质量问卷(MSQOL-54)的验证
Cureus. 2024 Nov 17;16(11):e73881. doi: 10.7759/cureus.73881. eCollection 2024 Nov.
2
Validation of the Indonesian version of multiple sclerosis quality of life-54 (MSQOL-54 INA) questionnaire.验证多发性硬化症生活质量量表-54 印尼版(MSQOL-54 INA)问卷。
Health Qual Life Outcomes. 2019 Jul 12;17(1):120. doi: 10.1186/s12955-019-1190-1.
3
Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire.多发性硬化症生活质量问卷波斯语版本的效度和信度
Neurol India. 2007 Oct-Dec;55(4):369-75. doi: 10.4103/0028-3886.33316.
4
Validation of the Disease-specific Questionnaire MSQoL-54 in Bosnia and Herzegovina Multiple Sclerosis Patients Sample.针对波斯尼亚和黑塞哥维那多发性硬化症患者样本的疾病特异性问卷MSQoL - 54的验证
Med Arch. 2017 Apr;71(2):103-106. doi: 10.5455/medarh.2017.71.103-106.
5
Validation of Persian Multiple Sclerosis quality of life-29 (P-MSQOL-29) questionnaire.验证波斯多发性硬化症生活质量问卷-29 项(P-MSQOL-29)。
Acta Neurol Belg. 2023 Dec;123(6):2201-2211. doi: 10.1007/s13760-023-02222-0. Epub 2023 Mar 18.
6
Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.多发性硬化症生活质量问卷(MSQOL - 54)在土耳其多发性硬化症样本中的跨文化适应与效度验证
J Neurol Sci. 2006 Jan 15;240(1-2):77-80. doi: 10.1016/j.jns.2005.09.009. Epub 2005 Nov 8.
7
Reliability and acceptability of the Multiple Sclerosis Quality of Life-29 questionnaire in an English-speaking cohort.多发性硬化症生活质量-29 问卷在讲英语人群中的可靠性和可接受性。
Mult Scler. 2019 Oct;25(11):1539-1542. doi: 10.1177/1352458518776583. Epub 2018 May 15.
8
[Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument].[日语版多发性硬化症生活质量-54量表的验证]
Rinsho Shinkeigaku. 2004 Jul;44(7):417-21.
9
Validation of The Slovenian Version of Multiple Sclerosis Quality of Life (MSQOL-54) Instrument.斯洛文尼亚语版多发性硬化症生活质量量表(MSQOL - 54)的验证
Zdr Varst. 2017 Oct 9;56(4):260-267. doi: 10.1515/sjph-2017-0035. eCollection 2017 Oct.
10
Validation of Italian multiple sclerosis quality of life 54 questionnaire.意大利多发性硬化症生活质量54问卷的验证
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):158-62. doi: 10.1136/jnnp.67.2.158.

引用本文的文献

1
Investigating the Psychometric Properties of the Persian Version of the Revised Illness Perception Questionnaire in a Sample of Patients With Multiple Sclerosis.在多发性硬化症患者样本中研究修订版疾病认知问卷波斯语版本的心理测量特性。
Brain Behav. 2025 Sep;15(9):e70821. doi: 10.1002/brb3.70821.
2
Depression, Anxiety, and MSQOL-54 Outcomes in RRMS Patients Receiving Fingolimod or Cladribine: A Cross-Sectional Comparative Study.接受芬戈莫德或克拉屈滨治疗的复发缓解型多发性硬化症患者的抑郁、焦虑及MSQOL-54结果:一项横断面比较研究
Medicina (Kaunas). 2025 Aug 3;61(8):1409. doi: 10.3390/medicina61081409.

本文引用的文献

1
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points.改善多发性硬化症患者生活质量的干预措施:新机遇与关键要点
Degener Neurol Neuromuscul Dis. 2023 Sep 19;13:55-68. doi: 10.2147/DNND.S395733. eCollection 2023.
2
Validation of the Indonesian version of multiple sclerosis quality of life-54 (MSQOL-54 INA) questionnaire.验证多发性硬化症生活质量量表-54 印尼版(MSQOL-54 INA)问卷。
Health Qual Life Outcomes. 2019 Jul 12;17(1):120. doi: 10.1186/s12955-019-1190-1.
3
"I'm not what I used to be": A qualitative study exploring how young people experience being diagnosed with a chronic illness.“我已非昔日之我”:一项质性研究,探索年轻人被诊断患有慢性病的经历。
Child Care Health Dev. 2019 Mar;45(2):216-226. doi: 10.1111/cch.12638. Epub 2019 Jan 27.
4
Lower prevalence of multiple sclerosis in First Nations Canadians.加拿大原住民中多发性硬化症的患病率较低。
Neurol Clin Pract. 2018 Feb;8(1):33-39. doi: 10.1212/CPJ.0000000000000418.
5
Validation of The Slovenian Version of Multiple Sclerosis Quality of Life (MSQOL-54) Instrument.斯洛文尼亚语版多发性硬化症生活质量量表(MSQOL - 54)的验证
Zdr Varst. 2017 Oct 9;56(4):260-267. doi: 10.1515/sjph-2017-0035. eCollection 2017 Oct.
6
Validation of the Disease-specific Questionnaire MSQoL-54 in Bosnia and Herzegovina Multiple Sclerosis Patients Sample.针对波斯尼亚和黑塞哥维那多发性硬化症患者样本的疾病特异性问卷MSQoL - 54的验证
Med Arch. 2017 Apr;71(2):103-106. doi: 10.5455/medarh.2017.71.103-106.
7
Brain health: time matters in multiple sclerosis.脑健康:时间在多发性硬化症中至关重要。
Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48. doi: 10.1016/j.msard.2016.07.003. Epub 2016 Jul 7.
8
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.多发性硬化症患者的就业状况:疾病特异性和非疾病特异性因素的影响。
Mult Scler. 2013 Nov;19(13):1792-9. doi: 10.1177/1352458513485655. Epub 2013 May 1.
9
Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample.针对塞尔维亚多发性硬化症患者样本的特定疾病问卷MSQOL - 54的验证与跨文化调适。
Qual Life Res. 2007 Oct;16(8):1383-7. doi: 10.1007/s11136-007-9234-0. Epub 2007 Jul 7.
10
Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.多发性硬化症生活质量问卷(MSQOL - 54)在土耳其多发性硬化症样本中的跨文化适应与效度验证
J Neurol Sci. 2006 Jan 15;240(1-2):77-80. doi: 10.1016/j.jns.2005.09.009. Epub 2005 Nov 8.

用于评估多发性硬化症患者生活质量的格鲁吉亚语版多发性硬化症生活质量问卷(MSQOL-54)的验证

Validation of the Georgian Version of the Multiple Sclerosis Quality of Life-54 (MSQOL-54) Questionnaire for Assessing the Quality of Life in Patients With Multiple Sclerosis.

作者信息

Khutsishvili Natalia, Nikoleishvili Elza, Beruchashvili Tina, Toidze Otar, Megrelishvili Marika, Ganugrava Nino

机构信息

School of Health Sciences and Public Health, University of Georgia, Tbilisi, GEO.

School of Medicine, Ilia State University, Tbilisi, GEO.

出版信息

Cureus. 2024 Nov 17;16(11):e73881. doi: 10.7759/cureus.73881. eCollection 2024 Nov.

DOI:10.7759/cureus.73881
PMID:39697968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11653053/
Abstract

BACKGROUND AND OBJECTIVES

Multiple sclerosis (MS) significantly impacts health-related quality of life (HRQOL). The Multiple Sclerosis Quality of Life-54 (MSQOL-54) is a widely used tool for assessing HRQOL in individuals with MS. Adapting this tool to the local language and culture is essential for ensuring cultural relevance, enabling comprehensive care, and allowing international comparability. This study aims to validate the Georgian version of the MSQOL-54 (MSQOL-54 GEO) and assess HRQOL in MS patients in Georgia.

METHODOLOGY

A cross-sectional study was conducted, involving 384 individuals with MS. The MSQOL-54 questionnaire was translated using a forward-backward translation technique. Statistical analysis, performed using SPSS 22.0, included internal consistency reliability measured by Cronbach's alpha coefficient (α) with 95% confidence intervals (95% CI), while external validity was determined through the correlation of individual components and composite scores with the Expanded Disability Status Scale (EDSS).

RESULTS

The MSQOL-54-GEO demonstrated strong validity and reliability, with most components showing Cronbach's alpha values above 0.70, except for the "Social Function" component. The "Health Perceptions" component recorded the lowest average score (47.3 ± 20.0). Significant correlations were found between MS duration and "Physical Health," as well as "Cognitive Function."

CONCLUSIONS AND IMPLICATIONS

The findings indicate that the MSQOL-54-GEO is a reliable, convenient, and accepted tool for assessing HRQOL among MS patients in Georgia. This validation contributes valuable insights into the internal consistency of the MSQOL-54-GEO, facilitating its essential use in clinical practice and research, for evaluating treatment outcomes and guiding holistic care approaches, encompassing physical, emotional, and social well-being.

摘要

背景与目的

多发性硬化症(MS)对健康相关生活质量(HRQOL)有显著影响。多发性硬化症生活质量-54量表(MSQOL-54)是评估MS患者HRQOL的广泛使用的工具。将该工具适用于当地语言和文化对于确保文化相关性、实现全面护理以及进行国际比较至关重要。本研究旨在验证MSQOL-54的格鲁吉亚语版本(MSQOL-54 GEO)并评估格鲁吉亚MS患者的HRQOL。

方法

进行了一项横断面研究,纳入384例MS患者。采用前后翻译技术对MSQOL-54问卷进行翻译。使用SPSS 22.0进行统计分析,包括用Cronbach's α系数(α)及95%置信区间(95%CI)测量的内部一致性信度,而外部效度则通过各单个分量与综合得分和扩展残疾状态量表(EDSS)之间的相关性来确定。

结果

MSQOL-54-GEO显示出很强的效度和信度,除“社会功能”分量外,大多数分量的Cronbach's α值高于0.70。“健康认知”分量的平均得分最低(47.3±20.0)。发现MS病程与“身体健康”以及“认知功能”之间存在显著相关性。

结论与启示

研究结果表明,MSQOL-54-GEO是评估格鲁吉亚MS患者HRQOL的可靠、便捷且被认可的工具。这一验证为MSQOL-54-GEO的内部一致性提供了有价值的见解,有助于其在临床实践和研究中用于评估治疗效果以及指导涵盖身体、情感和社会福祉的整体护理方法。